Bioisosterism in Drug Design: Classical & Non-Classical Bioisosteres

Added:

Bioisosterism Intro
Lead Optimization
Isostere Theory
Defining Bioisosteres
Drug Design Benefits
Classical Types
Drug Examples
Divident Examples
NSAID Design
Non-Classical Types

Bioisosterism Intro

0:00
Playing Section
  • 1

    Lecture explores bioisosterism's role in drug design.

  • 2

    Focuses on how small changes alter potency and safety.

  • 3

    Covers types, applications, and real-world drug examples.

Fundamental principles of organic chemistry, specifically functional groups, hybridization, and steric/electronic molecular properties.
The concept of Structure-Activity Relationships (SAR) and how chemical modifications affect a molecule's biological activity.
Basic understanding of drug-receptor interactions, including intermolecular forces like hydrogen bonding, electrostatic, and hydrophobic interactions.
The historical concept of chemical isosterism, including Irving Langmuir's definition and Grimm's Hydride Displacement Law.
Advanced lead optimization strategies in medicinal chemistry to improve ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) profiles.
The role of bioisosterism in avoiding patent infringement and establishing new 'me-too' drugs in the pharmaceutical market.
Design of peptidomimetics, substituting unstable peptide bonds with stable bioisosteric groups to improve oral bioavailability.
Application of Computer-Aided Drug Design (CADD) and bioisosteric replacement databases for virtual screening.
1K views21likes24:45@RFQ-09-18Original Release: 2025-03-20

Bioisosterism is a fundamental concept in medicinal chemistry where small structural modifications to drug molecules can significantly enhance their therapeutic properties by replacing functional groups with bioisosteric equivalents that maintain similar molecular shape, electronic distribution, and physicochemical properties while improving drug stability, potency, selectivity, and safety; this approach is classified into classical bioisosteres (which strictly follow steric and electronic definitions) and non-classical bioisosteres (which may share only partial characteristics), with real-world applications demonstrated in FDA-approved drugs such as 5-fluorouracil (uracil → fluorine), 6-mercaptopurine (hydroxyl → sulfur), losartan (carboxylic acid → tetrazole), and aspirin (salicylic acid → acetylsalicylic acid).